Chinese-made vaccine suspended for operating unauthorized plant in Brazil

News 09/07/21, 02:56

Brazil's health regulator temporarily blocked more than 12 million doses of Sinovac Biotech's COVID-19 vaccine on Sept. 4. Anvisa took regulatory action after receiving a complaint from Sao Paulo's Butantan Institute biomedical center. The center, which helps the Chinese firm manufacture locally, accused the Asian pharmaceutical company of unlawfully producing several ...

End of content

No more pages to load